PF-Atlas › Clinical Trials › NCT00075998

The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis

Interferon gamma-1b · Phase 3

Registry ID
NCT00075998
Phase
Phase 3
Status
Terminated
Drug / intervention
Interferon gamma-1b ("Actimmune")
Sponsor
InterMune
Start
2003-12

About this trial

Interferon gamma-1b is evaluated in NCT00075998, a Phase 3 idiopathic pulmonary fibrosis study sponsored by InterMune. Current status: Terminated.

View NCT00075998 on ClinicalTrials.gov →

Explore related

All Interferon gamma-1b trialsAll IPF trials

Related trials

interferon gamma-1b — NCT00043342interferon gamma-1b — NCT00043316
Medical disclaimer. This page summarizes public trial data for NCT00075998 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.